Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Journal of Family Medicine and Primary Care
|
July 29, 2024
Primary polycythaemia: A neglected risk factor
Nitin Rustogi, Ravi Talapa, Jitendra Yadav
Journal of Proteome Research
|
November 1, 2012
Proteomic profiling of breast tissue collagens and site-specific characterization of hydroxyproline residues of collagen alpha-1-(I)
Helen Montgomery, Nitin Rustogi, Andreas Hadjisavvas, et al.
Journal of Proteome Research
|
June 22, 2010
Quantitative proteomic profiling of matched normal and tumor breast tissues
Chris W Sutton, Nitin Rustogi, Cemal Gurkan, et al.
Scientific Reports
|
March 28, 2017
Towards reproducible MRM based biomarker discovery using dried blood spots
Sureyya Ozcan, Jason D Cooper, Santiago G Lago, et al.
Translational Psychiatry
|
November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals
Sung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.
Translational Psychiatry
|
February 13, 2019
Multimodel inference for biomarker development: an application to schizophrenia
Jason D Cooper, Sung Yeon Sarah Han, Jakub Tomasik, et al.
Brain, Behavior, and Immunity
|
April 5, 2022
Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia
Santiago G Lago, Jakub Tomasik, Geertje F van Rees, et al.
Translational Psychiatry
|
December 19, 2017
Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots
Jason D Cooper, Sureyya Ozcan, Renee M Gardner, et al.
Nucleic Acids Research
|
July 25, 2024
RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems
Uchechukwu Odunze, Nitin Rustogi, Paul Devine, et al.
Brain, Behavior, and Immunity
|
October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients
Geertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Journal of Family Medicine and Primary Care
|
July 29, 2024
Primary polycythaemia: A neglected risk factor
Nitin Rustogi, Ravi Talapa, Jitendra Yadav
Journal of Proteome Research
|
November 1, 2012
Proteomic profiling of breast tissue collagens and site-specific characterization of hydroxyproline residues of collagen alpha-1-(I)
Helen Montgomery, Nitin Rustogi, Andreas Hadjisavvas, et al.
Journal of Proteome Research
|
June 22, 2010
Quantitative proteomic profiling of matched normal and tumor breast tissues
Chris W Sutton, Nitin Rustogi, Cemal Gurkan, et al.
Scientific Reports
|
March 28, 2017
Towards reproducible MRM based biomarker discovery using dried blood spots
Sureyya Ozcan, Jason D Cooper, Santiago G Lago, et al.
Translational Psychiatry
|
November 9, 2019
Integrating proteomic, sociodemographic and clinical data to predict future depression diagnosis in subthreshold symptomatic individuals
Sung Yeon Sarah Han, Jason D Cooper, Sureyya Ozcan, et al.
Translational Psychiatry
|
February 13, 2019
Multimodel inference for biomarker development: an application to schizophrenia
Jason D Cooper, Sung Yeon Sarah Han, Jakub Tomasik, et al.
Brain, Behavior, and Immunity
|
April 5, 2022
Peripheral lymphocyte signaling pathway deficiencies predict treatment response in first-onset drug-naïve schizophrenia
Santiago G Lago, Jakub Tomasik, Geertje F van Rees, et al.
Translational Psychiatry
|
December 19, 2017
Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spots
Jason D Cooper, Sureyya Ozcan, Renee M Gardner, et al.
Nucleic Acids Research
|
July 25, 2024
RNA encoded peptide barcodes enable efficient in vivo screening of RNA delivery systems
Uchechukwu Odunze, Nitin Rustogi, Paul Devine, et al.
Brain, Behavior, and Immunity
|
October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients
Geertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
Page
of 3